APA (7th ed.) Citation

Bártolo, I., Borrego, P., Gomes, P., Gonçalves, F., Caixas, U., Pinto, I., & Taveira, N. (2018). In Vitro Evaluation of Novel Reverse Transcriptase Inhibitors TAF (Tenofovir Alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) Against Multi-Drug Resistant Primary Isolates of HIV-2.

Chicago Style (17th ed.) Citation

Bártolo, I., P. Borrego, P. Gomes, F. Gonçalves, U. Caixas, IV Pinto, and N. Taveira. In Vitro Evaluation of Novel Reverse Transcriptase Inhibitors TAF (Tenofovir Alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) Against Multi-Drug Resistant Primary Isolates of HIV-2. 2018.

MLA (8th ed.) Citation

Bártolo, I., et al. In Vitro Evaluation of Novel Reverse Transcriptase Inhibitors TAF (Tenofovir Alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) Against Multi-Drug Resistant Primary Isolates of HIV-2. 2018.